Developing countries could have lower priced drugs
Large employers could improve U.S. healthcare
The U.S. Patent Office could be reformed to lower drug prices
U.S. drug prices could be lower
Pharmaceutical industry acquisitions could inhibit drug innovation and raise drug prices
